Brought to you by:
Pay SVS dues to receive SVS benefits, including VAM discount
With registration for the 2023 Vascular Annual Meeting (VAM) right around the corner, those people who have not paid their SVS 2023 dues have a good incentive to do so quickly. Members receive a discount on not only VAM but…
First US patient enrolled in Gore Viafort vascular stent pivotal study
W L Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, randomized, multicenter, single-arm study with five-year follow-up to evaluate the investigational Gore Viafort vascular stent for the treatment of symptomatic inferior…
Getinge receives FDA premarket approval for the iCast covered stent system
Getinge‘s iCast covered stent system has received premarket approval from the Food and Drug Administration (FDA) for the treatment of patients with iliac arterial occlusive disease. The iCast covered stent system, sold outside the U.S. under the brand name Advanta…
Act now to keep CME credits, SVS urges members
Society for Vascular Surgery (SVS) members should act now so they do not lose earned continuing medical education (CME) credits. The American Board of Surgery (ABS) has changed its processes for CME credits, which affects their upload as well as…
Study highlights need for ‘continuous comparative assessments’ to guide endograft treatment decisions
A recent study comparing outcomes of endovascular aneurysm repair (EVAR) patients has reported no statistically significant differences in mortality or secondary rupture rates between standard Cook, Medtronic and Gore endografts, suggesting similar safety in a real-world setting. Michael O. Falster,…
STEVECO trial calls into question randomization in the venous stenting field
Recruitment proved to be a major challenge for the STEVECO (Stent versus conservative treatment in patients with deep venous obstruction) randomized controlled trial (RCT), prompting discussion on how best to randomize patients in future trials, the ethics of doing so,…
‘Time matters’: New study finds novel EHR workflow improves timeliness in vascular care
A novel, order-initiated workflow facilitated by the electronic health record (EHR) has been shown to improve timeliness of care for vascular surgery patients, decreasing time to operation and working to standardize and automate the consultation process. Presented at the 2023…
Analysis finds no difference in TCAR outcomes between academic, community hospitals
A new study found no difference in perioperative outcomes and incidence of adverse events at follow-up after transcarotid artery revascularization (TCAR) between academic and non-teaching community institutions. Presented at the 2023 winter annual meeting of the Vascular and Endovascular Surgery…
SVS, ACS launch new quality verification program
The Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) have launched the “Vascular Verification Program (Vascular-VP),” an ACS Quality Program developed in partnership with the SVS. The newly launched inpatient program reviews not just safety processes…
Bioprosthetic venous valve: ‘We want to know that this is really working’
A key investigator in efforts to tackle chronic venous insufficiency (CVI) with an bioprosthetic venous valve replacement talks about progress being made with surgical and endovascular versions of the device—and surgical community skepticism. Jorge Ulloa, MD, has not long since…